Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of ARQ 531 in Patients With Selected Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03162536
Recruitment Status : Recruiting
First Posted : May 22, 2017
Last Update Posted : May 3, 2021
Sponsor:
Information provided by (Responsible Party):
ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 1, 2022
Estimated Study Completion Date : September 1, 2022